Scientist Home Future Health Limited (SHFH)
| Market Cap | 40.32M |
| Revenue (ttm) | 400.74K -15.5% |
| Net Income | -400.50K |
| EPS | -0.02 |
| Shares Out | 23.72M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 1.700 |
| Previous Close | 1.700 |
| Day's Range | 1.700 - 1.700 |
| 52-Week Range | 1.700 - 12.000 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 11, 2026 |
About SHFH
Scientist Home Future Health Limited engages in the retail trading of health supplements and topical creams in Hong Kong and internationally. The company offers Scientist Home Vein Cream, for supporting vein health; Scientist Home Calcification Cream for addressing calcification problems associated with bone, joint and muscle health, as well as the cardiovascular system; and Scientist Home Spermaceti Cream, which targets joint and muscle discomfort for arthritis, tendon and ligament strains, and minor sprains and bruises. It also provides Scien... [Read more]
Financial Performance
Financial StatementsNews
Scientist Home Future Health Trial Demonstrates Significant Reduction in Eczema Symptoms using Evidence-based Nutritional Therapy
HONG KONG, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Scientist Home Future Health LTD (OTCID: SHFH) (Scientist home or ‘The Company') is pleased to announce Researchers at Scientist Home have announced promi...
Scientist Home Future Health Reports Second Quarter 2026 Financial Results
NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Scientist Home Future Health LTD (OTCID: SHFH) today reported financial results for the three and six months ended June 30, 2026.